Cleared Special

K101647 - WILDCAT 5F GUIDEWIRE SUPPORT CATHETER

K101647 is the FDA 510(k) clearance for WILDCAT 5F GUIDEWIRE SUPPORT CATHETER by Avinger, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 56-day FDA review.

K101647 · Avinger, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2010
Decision
56d
Days
Class 2
Risk

K101647 is an FDA 510(k) clearance for the WILDCAT 5F GUIDEWIRE SUPPORT CATHETER, MODE W500. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Avinger, Inc. (Redwood City, US). The FDA issued a Cleared decision on August 6, 2010 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Avinger, Inc. devices

Submission Details

510(k) Number K101647 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 2010
Decision Date August 06, 2010
Days to Decision 56 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 125d · This submission: 56d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 574
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K101647.
CONCENTRIC BALLOON GUIDE CATHETER
K102657 · Concentric Medical, Inc. · Nov 2010
MEDTRONIC C315 DELIVERY CATHETER
K101885 · Medtronic, Inc. · Sep 2010
HEADWAY 17 ADVANCED MICROCATHETER
K101542 · MicroVention, Inc. · Aug 2010
OCCLUSION BALLOON CATHETER MODEL OBC
K101877 · Cook, Inc. · Aug 2010
SCOUTPRO ACS
K101776 · Biotronik, Inc. · Jul 2010
SCOUTPRO HEMOSTATIC VALVE
K101282 · Biotronik, Inc. · Jul 2010